Results 171 to 180 of about 397,641 (267)
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS
The river diagram demonstrates that after transjugular intrahepatic portosystemic shunt insertion (TIPS) the majority of patients without ascites and 50% of the patients with ascites detectable at ultrasound, show the best response in the long term follow‐up.
Alexander Queck +14 more
wiley +1 more source
TTN variants in pediatric cardiomyopathy: a retrospective cohort study. [PDF]
Qiu Y, Liu L, Zhou K, Li Y, Hua Y.
europepmc +1 more source
Asymptomatic Hypertrophic Cardiomyopathy: Diagnosis and Therapy [PDF]
Fuentes, V L, Wilkie, L J
core +1 more source
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba +10 more
wiley +1 more source
Expression of Concern: Trends and disparities in dilated cardiomyopathy related mortality among adults in the United States: A CDC WONDER analysis (1999-2023). [PDF]
PLOS One Editors.
europepmc +1 more source
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler +8 more
wiley +1 more source
Second Hits Are Common Drivers of Genetic Heart Disease. [PDF]
MacKenzie D, Fullenkamp DE.
europepmc +1 more source
Cardiac CT for the Assessment of Ischemic Cardiomyopathy. [PDF]
Lee JW, Kang EJ, Hwang SH, Kim SM.
europepmc +1 more source
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia +2 more
wiley +1 more source
Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo +7 more
wiley +1 more source

